Current and emerging treatment options in triple-negative breast cancer
Triple-negative breast cancer is defined by the lack of estrogen receptor, progesterone receptor and HER2 expression with immunohistochemical analysis. Triplenegative breast cancers are poorly differentiated, characterized by high histological grade and occur at a younger age. Treatment options are...
Saved in:
Main Authors: | Omer Dizdar (Author), Kadri Altundag (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2011-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
by: Onyinyechi Obidiro, et al.
Published: (2023) -
Current landscape of personalized clinical treatments for triple-negative breast cancer
by: Jun Zhang, et al.
Published: (2022) -
TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
by: A. D. Zikiryakhodzhaev, et al.
Published: (2017) -
Immunotherapy Treatment for Triple Negative Breast Cancer
by: Elizabeth R. Berger, et al.
Published: (2021) -
Triple-negative breast cancer: current perspective on the evolving therapeutic landscape
by: Mehanna J, et al.
Published: (2019)